WARTICIDE

Dosage form: solution
Ingredients: SALICYLIC ACID 10g in 100mL
Labeler: The Sisquoc Healthcare Corporation
NDC code: 71229-105

Medically reviewed by Drugs.com. Last updated on Dec 13, 2024.

WARTICIDE

ACTIVE INGREDIENT

SALICYLIC ACID 10%

PURPOSE

WART REMOVER

USES

WART REMOVER

WARNINGS

FOR EXTERNAL USE ONLY.

DO NOT USE ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR.

WHEN USING THIS PRODUCT AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS, RINSE THE EYES VERY THOROUGHLY WITH WATER.

STOP USE AND ASK A DOCTOR IF IRRITATION OCCURS OR THERE IS NO IMPROVEMENT WITHIN 4 WEEKS.

KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

Simply unscrew the top and fill the dropper tip with liquid. Once full, apply Warticide to the wart or warts until the infected area is lightly covered with gel. Gently work Warticide into the wart with a finger and then wash hands after application is finished. Allow 3-4 minutes for the solution to absorb.

INACTIVE INGREDIENTS

WATER, ETHANOL, XANTHAN GUM, MELALEUCA ALTERNIFOLIA LEAF OIL, CEDAR LEAF OIL.

Store between 20°c to 25°C (68° to 77°F)

WARTICIDE
salicylic acid solution

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:71229-105
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (SALICYLIC ACID)	SALICYLIC ACID	10 g in 100 mL

Inactive Ingredients
Ingredient Name	Strength
WATER
ALCOHOL
XANTHAN GUM
TEA TREE OIL
CEDAR LEAF OIL

Packaging
#	Item Code	Package Description
1	NDC:71229-105-11	30 mL in 1 BOTTLE, DROPPER

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part358H	03/25/2019

Labeler - The Sisquoc Healthcare Corporation (021517142)

Establishment
Name	Address	ID/FEI	Operations
COASTAL CONTRACT PACKAGING, INC.		137341611	manufacture(71229-105)

Revised: 12/2019

Document Id: feaf056e-1d08-40b6-b120-e3442315d73b

Set id: d9aff395-18bb-4680-826e-e15025f73161

Version: 1

Effective Time: 20191223

The Sisquoc Healthcare Corporation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

WARTICIDE

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport